Alphamab Oncology (FRA:3NK)
1.170
+0.040 (3.54%)
At close: Nov 27, 2025
Alphamab Oncology Employees
Alphamab Oncology had 420 employees as of December 31, 2024. The number of employees decreased by 15 or -3.45% compared to the previous year.
Employees
420
Change (1Y)
-15
Growth (1Y)
-3.45%
Revenue / Employee
€193,017
Profits / Employee
€57,175
Market Cap
1.12B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 420 | -15 | -3.45% |
| Dec 31, 2023 | 435 | -37 | -7.84% |
| Dec 31, 2022 | 472 | 13 | 2.83% |
| Dec 31, 2021 | 459 | 125 | 37.43% |
| Dec 31, 2020 | 334 | 110 | 49.11% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Siemens Aktiengesellschaft | 318,000 |
| Deutsche Telekom AG | 198,194 |
| Mercedes-Benz Group AG | 175,264 |
| Bayerische Motoren Werke Aktiengesellschaft | 159,104 |
| Allianz SE | 156,626 |
| SAP SE | 109,121 |
| Siemens Energy AG | 103,000 |
| Deutsche Bank Aktiengesellschaft | 89,753 |